A business in context

ZIVO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-04-17 · 0001213900-26-047650

  2. 8-K · Current report

    Report date 2026-03-26 · 0001654954-26-002928 · Items 5.02,7.01,9.01

  3. 4 · Ownership change

    Report date 2026-02-27 · 0001654954-26-001833

  4. 4 · Ownership change

    Report date 2026-02-12 · 0001213900-26-016803

  5. 4 · Ownership change

    Report date 2026-02-10 · 0001654954-26-001157

  6. 4 · Ownership change

    Report date 2026-01-26 · 0001654954-26-000652

  7. 4 · Ownership change

    Report date 2026-01-26 · 0001654954-26-000651

  8. 4 · Ownership change

    Report date 2026-01-14 · 0001654954-26-000631

  9. 4 · Ownership change

    Report date 2026-01-14 · 0001654954-26-000630

  10. 8-K · Current report

    Report date 2025-12-19 · 0001654954-25-014296 · Items 5.02,9.01

  11. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001654954-25-013095

  12. 8-K · Current report

    Report date 2025-09-10 · 0001654954-25-010579 · Items 7.01,9.01

  13. 8-K · Current report

    Report date 2025-08-12 · 0001654954-25-009772 · Items 5.02

  14. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001654954-25-009650

  15. 8-K · Current report

    Report date 2025-07-08 · 0001654954-25-008035 · Items 1.01,2.03,9.01

  16. 8-K · Current report

    Report date 2025-06-09 · 0001654954-25-006837 · Items 5.07

  17. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001654954-25-005748

  18. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0001654954-25-004654

  19. 10-K · Annual report

    Report date 2024-12-31 · 0001654954-25-002948

  20. 8-K · Current report

    Report date 2025-01-22 · 0001654954-25-000805 · Items 3.02

  21. 8-K · Current report

    Report date 2025-01-09 · 0001654954-25-000453 · Items 1.01,9.01

  22. 8-K · Current report

    Report date 2025-01-07 · 0001654954-25-000173 · Items 8.01

  23. 8-K · Current report

    Report date 2024-11-12 · 0001654954-24-014503 · Items 1.01,2.03,9.01

  24. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001654954-24-014463

  25. 8-K · Current report

    Report date 2024-10-17 · 0001654954-24-013107 · Items 3.02

  26. SC 13D/A · Ownership disclosure

    0001618035-24-000005

  27. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001654954-24-010644

  28. 8-K · Current report

    Report date 2024-07-11 · 0001654954-24-009069 · Items 5.02

  29. 8-K · Current report

    Report date 2024-06-11 · 0001654954-24-007730 · Items 5.07

  30. SC 13D · Ownership disclosure

    0001654954-24-007677

  31. SC 13D · Ownership disclosure

    0001654954-24-007676

  32. SC 13D · Ownership disclosure

    0001654954-24-007675

  33. SC 13D/A · Ownership disclosure

    0001654954-24-007537

  34. 8-K/A · Current report

    Report date 2024-06-06 · 0001654954-24-007479 · Items 1.01

  35. 8-K · Current report

    Report date 2024-05-31 · 0001654954-24-007455 · Items 1.01,3.02,5.02,9.01

  36. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001654954-24-006082

  37. DEF 14A · Proxy statement

    Report date 2024-06-11 · 0001654954-24-005060

  38. SC 13D/A · Ownership disclosure

    0001174947-24-000523

  39. 10-K · Annual report

    Report date 2023-12-31 · 0001654954-24-003228

  40. 8-K · Current report

    Report date 2024-02-13 · 0001654954-24-001856 · Items 3.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 1 transaction rows1PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-17
2026-04-24
STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK EP · Purchase
Acquired
Common Stock100000.02.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001101026Zivo Bioscience, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • HEALTH ENHANCEMENT PRODUCTS INC · former SEC name · 2004-02-06 to 2014-10-16
  • WESTERN GLORY HOLE INC · former SEC name · 2000-06-19 to 2004-01-26

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$157.2K$167.4K
2023-12-31$27.6K$30.3K
2022-12-31$0$0
2021-12-31$0$0
2020-12-31$20.0K$25.8K
2019-12-31$0$0
2018-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗